Toggle navigation
Home
Pulse
Channels
CME
Profile
Home
Pulse
Channels
CME
Profile
David Vesole's Talks
David Vesole
Hackensack Meridian Health
CAR T-Cell Therapy in Myeloma: Targeting BCMA
July 30, 2026
David Vesole
Hackensack Meridian Health
00:00
--:--
Carvykti Efficacy & Response Rates
July 30, 2026
Share
Carvykti Efficacy & Response Rates
https://www.medspoke.co/channel_playlist?object_id=874&tap_id=13206
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
David Vesole
Hackensack Meridian Health
Post-Discharge CAR-T Toxicities
July 30, 2026
Why are you reporting this TALK?
